06 January 2004
Relationship of intercellular adhesion molecule-3 and hepatocyte growth factor with amyloidosis A in chronic renal-failure patients
Banu Bilezikci, Asuman Nihan Haberal, Beyhan DemirhanMed Sci Monit 2004; 10(1): CR25-28 :: ID: 11552
Abstract
Background:Patients with chronic renal failure have elevated serum levels of intercellular adhesion molecules and hepatocyte growth factor. The aim of this study was to investigate immunohistochemically whether these substances are associated with amyloidosis A in this patient group.Material/Methods: Liver needle-biopsy specimens from 40 chronic renal-failure patients, 20 with amyloidosis A (Group I) and 20 without this disease (Group II), were investigated. Twenty control liver biopsies were obtained from healthy individuals (Group III). All specimens were immunohistochemically stained to determine the presence and density of hepatocyte growth factor and intercellular adhesion molecule-3.Results: The levels of positivity for hepatocyte growth factor and intercellular adhesion molecule-3 in Groups I and II were significantly higher than the levels in the control group. Also, the Group I sections had significantly more cells that were positive for intercellular adhesion molecule-3 than the Group II sections (p<0.016). There was no significant difference between Groups I and II regarding the level of positivity for hepatocyte growth factor.
Conclusions: The fact that there was a higher density of intercellular adhesion molecule-3-positive cells in the patients with amyloidosis A indicates that this substance may be a microenvironmental factor in this disease. If this is true, regulating the serum level of this molecule may prevent amyloid A in chronic renal-failure patients.
Keywords: Amyloidosis - complications, Amyloidosis - metabolism, Amyloidosis - prevention & control, Case-Control Studies, Cell Adhesion Molecules - blood, Cell Adhesion Molecules - metabolism, Hepatocyte Growth Factor - metabolism, Kidney Failure, Chronic - complications, Kidney Failure, Chronic - metabolism, Liver - metabolism, Serum Amyloid A Protein - metabolism, Amyloidosis - prevention & control, Case-Control Studies, Cell Adhesion Molecules - metabolism, Hepatocyte Growth Factor - metabolism, Kidney Failure, Chronic - metabolism, Liver - metabolism, Serum Amyloid A Protein - metabolism
Editorial
01 November 2024 : Editorial
Editorial: Artificial Intelligence (AI), Digital Image Analysis, and the Future of Cancer Diagnosis and PrognosisDOI: 10.12659/MSM.947038
Med Sci Monit 2024; 30:e947038
In Press
Clinical Research
Adipose-Derived Mesenchymal Stem Cells from Arthritis Patients: Differential Modulation of CD4⁺ T Cell Acti...Med Sci Monit In Press; DOI: 10.12659/MSM.945273
Review article
Surgical Advances in the Treatment of Acromioclavicular Joint Injury: A Comprehensive ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.942969
Clinical Research
Analysis of Mortality Causes and Locations in Veterans with ALS: A Decade ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.945816
Clinical Research
Impact of Prior Cesarean Delivery on Pregnancy Outcomes and Hemorrhage Risks in Complete Placenta Previa: A...Med Sci Monit In Press; DOI: 10.12659/MSM.944432
Most Viewed Current Articles
17 Jan 2024 : Review article 6,511,914
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,913,219
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 695,669
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 261,779
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074